Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?

Front Immunol · 2021 · PMC8374888 · PMID 34421889

Europe PMC DOI

hedged sentence

0.4000

closest p · 8.0× alpha

0.4000

boldest claim

The sentences

showed a trendp = 0.40not close (p > 0.1)

Patients with overweight or obesity who received only anti-PD-1 showed a trend toward worse PFS (p = 0.40) but no clear change in OS (p = 0.35) ( 37 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.